摘要：在医学研究的浩瀚星空中，每一项研究成果的发布都如同星辰般璀璨，既照亮了科学的道路，也可能隐藏着不为人知的秘密。近期，《柳叶刀》杂志上发表的一项关于中药复方FYTF-919对于中重度急性脑出血患者疗效的研究，便如同一颗神秘的星辰，不仅引发了医学界的广泛关注，更在
在医学研究的浩瀚星空中，每一项研究成果的发布都如同星辰般璀璨，既照亮了科学的道路，也可能隐藏着不为人知的秘密。近期，《柳叶刀》杂志上发表的一项关于中药复方FYTF-919对于中重度急性脑出血患者疗效的研究，便如同一颗神秘的星辰，不仅引发了医学界的广泛关注，更在国家安全与中医药秘方保护的领域投下了深深的阴影。
这项由复旦大学、广东中医药大学等26家医院联合进行的研究，历时两年，筛查了9000名患者，最终1648名被随机分配到治疗组，旨在探究中药复方FYTF-919对于中重度急性脑出血患者的功能恢复、生存率和健康相关生活质量的影响。然而，研究结果却如同一盆冷水，浇灭了人们对这一中药制剂的期待——中药在改善早期神经功能恶化、生存率和生活质量方面与安慰剂相比没有显著差异。这一结论，无疑对中药的疗效评估提出了新的挑战，但在这背后，却隐藏着更为复杂的逻辑。
从国家安全的角度来看，中药复方FYTF-919的研究结果或许并非偶然。在全球化日益加深的今天，国家安全不仅局限于传统的军事、政治领域，更涵盖了经济、文化、科技等多个方面。中医药作为我国独特的医疗资源和文化瑰宝，其安全性和有效性直接关系到国家的健康安全和文化传承。然而，随着中医药的国际化进程加速，一些西方国家开始觊觎我国的中医药秘方，企图通过窃取或仿制来抢占市场。
在这样的背景下，中药复方FYTF-919的研究结果或许可以被视为一种策略性的“烟雾弹”。通过国际标准化实验方法评估中药疗效，虽然结果显示中药无效，但这一研究过程本身却为传统医学的评估提供了一种新的科学途径。更重要的是，这一研究结果可能让西方国家对我国中医药秘方的真实疗效产生误解，从而在一定程度上保护了中医药秘方的安全。
想象一下，如果中药复方FYTF-919的研究结果显示其疗效显著，那么西方国家可能会更加积极地寻求窃取或仿制这一秘方。而一旦秘方泄露，不仅会导致我国中医药产业的巨大损失，更可能威胁到国家的文化安全和健康安全。因此，从这个角度来看，中药复方FYTF-919的“无效”结果或许是一种有意为之的策略，旨在迷惑西方国家，保护中医药秘方的安全。
当然，这种猜测并非无的放矢。在历史上，中医药秘方曾多次遭到窃取或仿制。例如，某些西方制药公司曾通过不正当手段获取我国的中药秘方，并在此基础上开发出类似的药物，从而抢占市场。这些事件不仅给我国中医药产业带来了巨大的经济损失，更让中医药秘方的安全受到了严重威胁。
因此，从这个角度来看，中药复方FYTF-919的“无效”结果或许可以被视为一种“防御性”的策略。通过在国际顶级医学期刊上发表这一研究结果，我国不仅展示了中医药研究的科学性和严谨性，更在一定程度上迷惑了西方国家，保护了中医药秘方的安全。
然而，需要强调的是，这种猜测并不意味着中药复方FYTF-919本身真的无效。相反，这一研究结果可能只是反映了在当前的研究条件下，该药物对于特定患者群体的疗效并不显著。因此，我们不能因为这一研究结果就全盘否定中医药的价值和效用。相反，我们应该更加深入地研究中医药的作用机制和应用范围，以更好地发挥其疗效和优势。
综上所述，中药复方FYTF-919的研究结果或许并非偶然，而是隐藏着更为复杂的逻辑。从国家安全的角度来看，这一研究结果可能是一种策略性的“烟雾弹”，旨在迷惑西方国家，保护中医药秘方的安全。然而，无论这一猜测是否成立，我们都应该更加深入地研究中医药的疗效和优势，以更好地服务于人类的健康事业。
作者简介：梁世杰 中医高年资主治医师，从事中医临床工作24年，积累了较丰富的临床经验。师从首都医科大学附属北京中医院肝病科主任医师、著名老中医陈勇，侍诊多载，深得器重，尽得真传！擅用“商汤经方分类疗法”、专病专方结合“焦树德学术思想”“关幼波十纲辨证”学术思想治疗疑难杂症为特色。现任北京厚德为怀医生集团渐冻症研究中心主任，北京树德堂中医研究院研究员，北京中医药薪火传承新3+3工程—焦树德门人（陈勇）传承工作站研究员，国际易联易学与养生专委会常务理事，中国中医药研究促进会焦树德学术传承专业委员会委员，中国药文化研究会中医药慢病防治分会首批癌症领域入库专家。荣获2020年中国中医药研究促进会仲景医学分会举办的第八届医圣仲景南阳论坛“经方名医”荣誉称号。2023年首届京津冀“扁鹊杯”燕赵医学研究主题征文优秀奖获得者。
What is the rationale behind the ineffectiveness of Chinese preparation of Chinese materia medica?
In the vast galaxy of medical research, each discovery shines like a star, illuminating both the path of science and potentially hidden secrets. FYTF-919 in the treatment of moderate to severe acute cerebral hemorrhage. It is like a mysterious star, which has not only caused widespread concern in the medical community, but also cast a deep shadow on national security and the protection of traditional Chinese medicine prescriptions.
The study, conducted by 26 hospitals including Fudan University and Guangdong University of Chinese Medicine, lasted two years. The aim of this study was to investigate the effects of FYTF-919 on functional recovery, survival, and health-related quality of life in patients with moderate to severe acute cerebral hemorrhage. However, the results have dampened expectations that the preparation of Chinese materia medica does not significantly improve early neurological deterioration, survival, or quality of life compared to placebos. This conclusion undoubtedly poses new challenges to the evaluation of the efficacy of Chinese medicine, but behind it lies a more complex logic.
From the perspective of national security, the results of the study of Chinese herbal compound FYTF-919 may not be accidental. In today's deepening globalization, national security is not limited to the traditional military and political fields, but also encompasses economic, cultural, scientific and technological aspects. As China's unique medical resource and cultural treasure, traditional Chinese medicine's safety and effectiveness are directly related to the country's health and safety and cultural inheritance. However, as the internationalization of traditional Chinese medicine has accelerated, some Western countries have begun to covet the secret recipes of Chinese medicine, attempting to grab the market by stealing or copying them.
In this context, the results of the study of Chinese herbal compound FYTF-919 may be regarded as a strategic "fog bomb." The effectiveness of traditional Chinese medicine was evaluated through internationally standardized experimental methods, and although the results showed that traditional medicine was not effective, the research process itself provided a new scientific approach to the evaluation of traditional medicine. More importantly, this research finding may cause Western countries to misunderstand the true efficacy of Chinese traditional Chinese medicine, thereby protecting the safety of Chinese herbal medicine to a certain extent.
Imagine if the results of studies on the Chinese herbal compound FYTF-919 show significant efficacy, then Western countries may be more aggressive in seeking to steal or copy the secret recipe. Once the secret recipe is leaked, it will not only lead to huge losses of Chinese medicine industry, but also threaten the cultural security and health security of the country. Therefore, from this point of view, the "ineffective" results of the traditional Chinese medicine compound FYTF-919 may be a deliberate strategy to confuse the Western countries and protect the safety of traditional Chinese medicine secret recipes.
Of course, this speculation is not ill-targeted. Historically, the secret recipes of Chinese medicine have been stolen or copied many times. For example, certain Western pharmaceutical companies have improperly obtained the secret recipes of Chinese traditional medicine and developed similar drugs on the basis of this, thus taking over the market. These incidents not only brought huge economic losses to China's traditional Chinese medicine industry, but also severely threatened the safety of traditional Chinese medicinal recipes.
Therefore, from this perspective, the "ineffective" results of the herbal compound FYTF-919 may be seen as a "defensive" strategy. By publishing this research finding in the top international medical journals, China has not only demonstrated the scientificity and rigor of traditional Chinese medicine research, but has also confused Western countries to a certain extent and protected the safety of traditional traditional Chinese remedies.
However, it should be emphasized that this speculation does not mean that the herbal compound FYTF-919 itself is really ineffective. Instead, this finding may simply reflect that the drug's efficacy for a specific patient population is not significant under the current study conditions. Therefore, we cannot deny the value and utility of Chinese medicine entirely because of the results of this study. Instead, we should study the mechanism of action and range of application of Chinese medicine in greater depth to better realize its efficacy and advantages.
In summary, the results of the Chinese herbal compound FYTF-919 may not be accidental, but hidden more complex logic. From a national security perspective, the findings could be a strategic "smoke bomb" aimed at confusing Western countries and protecting the safety of traditional Chinese medicine's secret recipes. However, whether or not this hypothesis is true, we should study the efficacy and advantages of traditional Chinese medicine in greater depth to better serve the human health cause.
Author Bio: Liang Shijie is a senior medical practitioner in traditional Chinese medicine. He has been engaged in traditional medicine clinical work for 24 years and has accumulated a wealth of clinical experience. Following Chen Yong, chief physician of liver disease at Beijing Traditional Medicine Hospital, affiliated with Capital Medical University, and renowned old Chinese medicine, he has been treated for many years and received great attention. He specializes in the treatment of difficult diseases using "conversational traditional therapy" and special treatments combined with the academic ideas of Jiao Shude and Guan Yubo's ten-level diagnosis.He is currently the director of the Center for Diffusion Research of Dr. Houde Wei Group in Beijing, a researcher at the Shude Tang Institute of Chinese Medicine, and a fellow at the new 3 + 3 project of traditional Chinese medicine flame inheritance in Beijing - a scholar at the inheritance work station of Jiao Shude's protégés (Chen Yong),He is a standing committee member of the International Expert Committee on E-learning and Health Care, a member of the Jiao Shude Academic Heritage Special Committee of the Chinese Association for the Advancement of Chinese Medicine Research, and the first cancer specialist to be included in the chapter of the Chinese Pharmaceutical Culture Research Association. Won the 2020 China Association for the Promotion of Traditional Chinese Medicine Zhongjing Medical Branch held the eighth session of the Medical Saint Zhongjing Nanyang Forum "Classic Prescription Famous Doctor" honorary title. The winner of the first Beijing-Tianjin-Hebei "Pingui Cup" Yanzhao Medical Research Essay Award in 2023.
来源：首都专家梁世杰一点号